We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArcontech Group Regulatory News (ARC)

Share Price Information for Arcontech Group (ARC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 106.50
Bid: 105.00
Ask: 108.00
Change: 0.00 (0.00%)
Spread: 3.00 (2.857%)
Open: 106.50
High: 106.50
Low: 106.50
Prev. Close: 106.50
ARC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

18 Aug 2014 07:00

RNS Number : 3214P
Arcontech Group PLC
18 August 2014
 

Arcontech Group plc

 

("Arcontech", the "Company" or the "Group")

 

Final Results for the Year Ended 30 June 2014

 

 

Chairman's Statement

 

Arcontech has achieved a significantly improved operating result for the year ended 30 June 2014, with a loss before taxation and exceptional items of £35,565 (2013: loss before taxation and exceptional items of £340,750). After taking the benefit of the Research and Development tax credit of £100,251 (2013: £88,905) which the company receives due to the amount it has invested in qualifying product design and development, Arcontech achieved a profit after tax of £64,686 (2013: loss after tax of £251,845).

 

Turnover for the year was £1,981,375 (2013: £1,830,717), an increase of 8%. This increase, whilst positive, is lower than we would have hoped to achieve due in part to the continued lengthening of sales cycles and to customers prioritising areas subject to greater regulatory focus than those addressed by our products. However, at 30 June 2014 the annual recurring licence fees amounted to £1,985,355 (2013: £1,884,778) representing 98% of our annualised running costs (2013: 87%).

 

As a result of negative distributable reserves, Arcontech has not been able to declare a dividend (2013:£Nil). We intend, however, when the company moves into sustainable profitability, to seek court approval to re-designate our reserves and thereby enable the company to pay dividends.

 

Financing

 

As at 30 June 2014 Arcontech had no debt and cash balances of £733,676 (2013: £878,804), this reduction being due to the timing of sales invoicing and of cash receipts from customers. Nevertheless, the company remains well financed.

 

Employees

 

Our employees are core to our business. They have responded positively to the challenges presented by a competitive market place during the last financial year and we again thank them for their continued hard work, dedication and support.

 

Outlook

 

With Arcontech's lower cost base and improved product offering we believe that the company is well placed to continue to grow its revenues. The level of sales prospects the company has are significant, however the timing of their conversion into actual sales orders is, as in previous years, extremely difficult to predict. We remain convinced that opportunities for the sale of our products to international investment banks, central banks and other financial institutions remain strong.

 

Richard Last

Chairman

 

 

Chief Executive's Review

 

During the year we have continued to work on positioning the business so that we have a solid, efficient and effective platform from which to grow. At the same time we have worked with our existing clients to strengthen and grow our relationships whilst also prospecting for new opportunities. In both areas we have succeeded and are now well positioned to move forward.

 

We have managed to reduce costs in running the organisation so that it is efficient and productive with all areas complementing each other in our goal for growth. We implemented stricter controls on development to ensure work undertaken generated revenue and contributed to making our offerings more competitive.  We also improved the way in which we test our software by building out automated processes where possible, which although requiring human input at the scripting phase does not require subsequent repetitive and costly human intervention.

 

Growing the business has been successful too, in a very challenging market. Ongoing issues in the marketplace such as the LIBOR-fixing scandal and staff reductions have served to prolong decision making.  Despite this we managed to grow revenues by 8% and we are pleased to say we believe Excelerator to be the leading Excel Add-In in the financial market-place with one client having rolled out more than 300 positions across the organisation. We are also happy to have secured the world's oldest international financial organisation as a new MVCS client.

 

More generally we have also expanded our discussions with clients to identify additional areas in which we can add value to embed us further within their businesses and to aid development of our product portfolio. At the same time we have continued to improve our marketing function which, together with our overall business and sales strategy, increasingly addresses issues of regulation and compliance.

 

As we build on what has been done and develop these areas I look forward to achieving greater progress.

 

Matthew Jeffs

Chief Executive

 

 

For further information please visit www.arcontech.com 

 

Enquiries

 

Arcontech Group plc

Matthew Jeffs, CEO

 

+44 20 7256 2300

Northland Capital Partners Limited

Matthew Johnson / Lauren Kettle

 

+44 20 7382 1100

 

 

 

Group Income Statement and Statement of Comprehensive Income

 

For the year ended 30 June 2014

 

 

 

Note

 

 

 

2014

Before

exceptional items

2013

Exceptional items

2013

 

Total 2013

 

 

£

£

£

 

£

 

 

 

 

 

 

 

Revenue

2

1,981,375

1,830,717

-

 

1,830,717

 

 

 

 

 

 

 

Distribution costs

 

(31,439)

(28,468)

-

 

(28,468)

 

 

 

 

 

 

 

Administrative costs

 

 

(1,989,156)

 

(2,150,126)

(160,994)

 

 

(2,311,120)

 

 

 

 

 

 

 

 

Operating loss

3

 

(39,220)

 

(347,877)

(160,994)

 

 

(508,871)

 

 

 

 

 

 

 

Finance income

 

3,655

7,127

-

 

7,127

 

Loss before taxation

 

 

(35,565)

 

(340,750)

(160,994)

 

 

(501,744)

 

 

 

 

 

 

 

 

Taxation

 

 

100,251

 

88,905

-

 

 

88,905

 

Profit/(loss) for the year after tax

 

 

64,686

 

(251,845)

(160,994)

 

 

(412,839)

 

Total comprehensive income for the year

 

 

64,686

 

(251,845)

(160,994)

 

 

(412,839)

 

Profit/(loss) per share (basic and diluted)

4

 

0.004p

 

 

 

 

 

(0.027)p

 

All of the results relate to continuing operations.

 

 

 

Statement of Changes in Equity

 

For the year ended 30 June 2014

 

Group:

 

Share

capital

Share

premium

Share option reserve

Retained

earnings

Total

equity

 

£

£

£

£

£

Balance at 30 June 2012

1,531,315

9,428,169

190,760

(9,473,857)

1,676,387

 

 

 

 

 

 

Loss for the year

-

-

-

(412,839)

(412,839)

 

Total comprehensive income for the year

-

-

-

(412,839)

(412,839)

 

 

 

 

 

 

Share-based payments

-

-

62,474

-

62,474

 

 

 

 

 

 

Balance at 30 June 2013

1,531,315

9,428,169

253,234

(9,886,696)

1,326,022

 

 

 

 

 

 

Profit for the year

-

-

-

64,686

64,686

 

Total comprehensive income for the year

-

-

-

64,686

64,686

 

Issue of shares

5,357

2,143

-

-

7,500

 

 

 

 

 

 

Share-based payments

-

-

18,677

-

18,677

 

Share-based payments provision released

-

-

(199,349)

199,349

-

 

Balance at 30 June 2014

1,536,672

9,430,312

72,562

(9,622,661)

1,416,885

 

Company:

 

Share

capital

Share

premium

Share option reserve

Retained

earnings

Total

equity

 

£

£

£

£

£

Balance at 30 June 2012

1,531,315

9,428,169

190,760

(7,565,688)

3,584,556

 

 

 

 

 

 

Loss for the year

-

-

-

(189,820)

(189.820)

 

Total comprehensive income for the year

-

-

-

(189,820)

(189.820)

 

 

 

 

 

 

Share-based payments

-

-

62,474

-

62,474

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 30 June 2013

1,531,315

9,428,169

253,234

(7,755,508)

3,457,210

 

 

 

 

 

 

Profit for the year

-

-

-

23,186

23,186

 

Total comprehensive income for the year

-

-

-

23,186

23,186

 

 

 

 

 

 

Issue of shares

5,357

2,143

-

-

7,500

 

 

 

 

 

 

Share-based payments

-

-

18,677

-

18,677

 

 

 

 

 

 

Share-based payments provision released

-

-

(199,349)

53,091

(146,258)

Balance as at 30 June 2014

1,536,672

9,430,312

72,562

(7,679,231)

3,360,315

 

 

Balance Sheets

 

As at 30 June 2014

 

 

 

Group2014£

 

Group2013£

 

Company2014£

 

Company2013

£

 

 

 

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Goodwill

 

1,715,153

 

1,715,153

 

-

 

-

 

 

 

 

 

 

 

 

 

Property, plant and equipment

 

19,112

 

25,044

 

-

 

-

 

 

 

 

 

 

 

 

 

Investments in subsidiaries

 

-

 

-

 

2,017,373

 

2,017,373

Total non-current assets

 

1,734,265

 

1,740,197

 

2,017,373

 

2,017,373

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade and other receivables

 

361,016

 

591,780

 

1,510,725

 

1,648,084

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

733,676

 

878,804

 

37,854

 

54,817

Total current assets

 

1,094,692

 

1,470,584

 

1,548,579

 

1,702,901

 

 

 

 

 

 

 

 

 

Current liabilities

Trade and other payables

(1,412,072)

(1,884,759)

(205,637)

(263,064)

Total current liabilities

(1,412,072)

(1,884,759)

(205,637)

(263,064)

 

 

 

 

 

 

 

Net current (liabilities)/assets

(317,380)

 

(414,175)

 

1,342,942

 

1,439,837

 

 

 

 

 

 

 

Net assets

 

1,416,885

 

1,326,022

 

3,360,315

 

3,457,210

 

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Called up share capital

 

1,536,672

 

1,531,315

 

1,536,672

 

1,531,315

 

 

 

 

 

 

 

 

 

Share premium account

 

9,430,312

 

9,428,169

 

9,430,312

 

9,428,169

 

 

 

 

 

 

 

 

 

Share option reserve

 

72,562

 

253,234

 

72,562

 

253,234

 

 

 

 

 

 

 

 

 

Retained earnings

 

(9,622,661)

 

(9,886,696)

 

(7,679,231)

 

(7,755,508)

 

 

1,416,885

1,326,022

 

3,360,315

 

3,457,210

 

Approved on behalf of the board on 15 August 2014 by:

 

 

Matthew Jeffs

Michael Levy

Chief Executive

Group Finance Director

 

 

Group Cash Flow Statement

 

For the year ended 30 June 2014

 

 

Note

2014

 

2013

 

 

 

£

 

£

 

 

 

 

 

 

 

Net cash ( used in)/generated from operating activities

 

(151,013)

 

130,081

 

 

Investing activities

 

 

 

 

 

 

 

 

 

 

 

Interest received

 

3,655

 

7,127

 

 

 

 

 

 

 

Purchases of plant and equipment

 

(5,270)

 

(5,079)

 

 

 

 

 

 

 

Issue of shares

 

7,500

 

-

 

 

Net cash generated from investing activities

 

5,885

 

2,048

 

 

Net (decrease)/increase in cash and cash equivalents

 

(145,128)

 

132,129

 

 

 

 

 

 

 

Cash and cash equivalents at beginning of year

 

878,804

 

746,675

 

 

Cash and cash equivalents at end of year

 

733,676

 

878,804

 

 

 

 

Company Cash Flow Statement

 

For the year ended 30 June 2014

 

 

 

2014

 

2013

 

 

 

£

 

£

 

 

Net cash (used in)/generated from operating activities

 

(24,652)

 

16,915

 

 

Investing activities

 

 

 

 

 

 

 

 

 

 

 

Interest received

 

189

 

307

 

 

 

 

 

 

 

Issue of shares

 

7,500

 

-

 

 

Net cash generated from investing activities

 

7,689

 

307

 

 

Net (decrease)/increase in cash and cash equivalents

 

(16,963)

 

17,222

 

 

 

 

 

 

 

Cash and cash equivalents at beginning of year

 

54,817

 

37,595

 

 

Cash and cash equivalents at end of year

 

37,854

 

54,817

 

 

 

Notes to the Financial Statements

 

For the year ended 30 June 2014

 

1. Accounting policies

 

The principal accounting policies are summarised below. They have all been applied consistently throughout the period covered bythese financial statements.

 

Reporting entity

 

Arcontech Group PLC ("the Company") is a company incorporated in the United Kingdom. The consolidated financial statements incorporate the financial statements of the Company and its subsidiaries (together referred to as "the Group").

 

Basis ofpreparation

 

The financial information set out above for the years ended 30 June 2014 and 2013 does not constitute the Group's statutory accounts within the meaning of Section 434 of the Companies Act 2006 but is derived from those accounts. Statutory accounts for the year ended 30 June 2013 have been delivered to the Registrar of Companies and those for 2014 will be delivered following the Company's annual general meeting. The auditors have reported on those accounts. The auditors' reports were unqualified and did not contain statements under s.498 (2) or (3) Companies Act 2006. The results have been prepared using accounting policies consistent with those used in the preparation of the statutory accounts.

 

The financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") endorsed by the European Union and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS.

 

The financial statements have been prepared under the historical cost convention.

 

2. Revenue

 

An analysis of the Group's revenue is as follows:

 

 

 

2014£

 

2013£

 

 

 

 

 

 

 

Financial information service, advertising and sponsorship, software development and consultancy

 

1,981,375

 

1,830,717

 

 

All of the Group's revenue relates to continuing activities.

 

3. Operating loss for the year is stated after charging:

 

 

 

2014£

 

2013£

 

Depreciation of plant and equipment

 

10,736

 

13,951

 

Loss on disposal of fixed assets

 

465

 

346

 

Staff costs

 

1,476,944

 

1,645,544

 

Operating lease rentals - land and buildings

 

79,000

 

79,000

 

Research and development

 

736,867

 

729,095

 

 

 

4. Loss per share

 

 

 

2014

 

2013

 

 

 

£

 

£

 

Earnings

 

 

 

 

 

Earnings for the purpose of basic and diluted earnings per share being net profit/(loss) attributable to equity shareholders

 

64,686

 

(412,839)

 

 

 

64,686

 

(412,839)

 

 

 

 

No.

 

No.

 

Number of shares

 

 

 

 

 

Weighted average number of ordinary shares for the purpose of basic earnings per share

 

1,531,505,672

 

1,531,314,870

 

 

 

 

 

 

 

Number of dilutive shares under option

 

13,314,419

 

-

 

Weighted average number of ordinary shares for the purposes of dilutive earnings per share

 

1,544,820,092

 

1,531,314,870

 

 

The calculation of diluted earnings per share assumes conversion of all potentially dilutive ordinary shares, all of which arise from share options. A calculation is done to determine the number of shares that could have been acquired at fair value, based upon the monetary value of the subscription rights attached to outstanding share options.

 

5. Dividends

 

There were no dividends paid or proposed during the period (2013: £Nil).

 

6. Post balance sheet events

 

There were no events since the balance sheet date, which materially affect the position of the Group.

 

7. Annual General Meeting

 

The annual general meeting of the "Company" will be held at the Company's offices, 8th Floor, Finsbury Tower, 103-105 Bunhill Row, London EC1Y 8LZ on 29 October 2014 at 10 a.m.

 

8. Annual report and accounts

 

Copies of the annual report and accounts will be sent to shareholders in due course and will be available from the Company Secretary at the Company's registered office at 8th Floor Finsbury Tower, 103-105 Bunhill Row, London, EC1Y 8LZ or from the Company's website at www.arcontech.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR QKPDQPBKDFFD
Date   Source Headline
21st Feb 20247:00 amRNSInterim Results
27th Oct 20237:00 amRNSNew Client Win
25th Oct 20231:42 pmRNSResult of AGM
3rd Oct 20235:40 pmRNSPosting of Annual Report & Notice of AGM
5th Sep 20237:00 amRNSFinal Results
24th Jul 20237:00 amRNSTrading Update and Notice of Results
10th May 20237:00 amRNSAppointment of consultant in Singapore
6th Apr 202311:45 amRNSDirector/PDMR Shareholding
3rd Apr 20237:00 amRNSDirector Retirement
27th Feb 20237:00 amRNSInterim Results
26th Oct 20223:15 pmRNSBoard Appointment
21st Oct 20227:00 amRNSGrant of Options
17th Oct 20222:41 pmRNSResult of AGM
17th Oct 20222:41 pmRNSResult of AGM
23rd Sep 20224:30 pmRNSPosting of Annual Report & Notice of AGM
12th Sep 20227:00 amRNSFinal Results
30th Aug 20227:00 amRNSNotice of Results
29th Jun 20227:00 amRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSInterim Results
17th Jan 20224:30 pmRNSDirector/PDMR Shareholding
29th Nov 20219:06 amRNSSecond Price Monitoring Extn
29th Nov 20219:00 amRNSPrice Monitoring Extension
29th Nov 20217:00 amRNSTrading Update
15th Oct 20215:32 pmRNSDirector/PDMR Shareholding
12th Oct 20215:00 pmRNSGrant of Options
11th Oct 20217:00 amRNSHolding(s) in Company
1st Oct 20213:30 pmRNSResult of AGM
8th Sep 20217:00 amRNSPosting of Annual Report & Notice of AGM
8th Sep 20217:00 amRNSExercise of Options
7th Sep 20217:00 amRNSExercise of Options, Director/PDMR Shareholding
1st Sep 20214:41 pmRNSSecond Price Monitoring Extn
1st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSFinal Results
10th Aug 20217:00 amRNSNotice of Results
12th Mar 202112:16 pmRNSHolding(s) in Company
23rd Feb 20217:00 amRNSInterim Results
22nd Jan 20214:30 pmRNSIssue of Equity
16th Oct 20207:00 amRNSAgreement to upgrade longstanding Tier 1 Client
5th Oct 20203:03 pmRNSGrant of Options
2nd Oct 202011:05 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSNew client win to contribute data to Factset
29th Sep 202010:53 amRNSResult of AGM
10th Sep 20207:00 amRNSIssue of Equity & PDMR Shareholding
8th Sep 20207:00 amRNSPosting of Annual Report & Notice of AGM
2nd Sep 20207:00 amRNSFinal Results
27th Aug 20201:59 pmRNSNotice of Results
20th Jul 20207:00 amRNSBoard appointment
15th Jul 20207:00 amRNSTrading Update / Notice of Results
1st Jun 20207:00 amRNSDirectorate change & Appointment of CoSec

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.